User menu

Multimodal imaging of tumor response to sorafenib combined with radiation therapy: comparison between diffusion-weighted MRI, choline spectroscopy and 18F-FLT PET imaging

Bibliographic reference Karroum, Oussama ; Mignion, Lionel ; Kengen, Julie ; Karmani, Linda ; Levêque, Philippe ; et. al. Multimodal imaging of tumor response to sorafenib combined with radiation therapy: comparison between diffusion-weighted MRI, choline spectroscopy and 18F-FLT PET imaging. In: Contrast Media & Molecular Imaging, Vol. 8, no. 3, p. 274-280 (2013)
Permanent URL
  1. Therasse Patrick, Arbuck Susan G., Eisenhauer Elizabeth A., Wanders Jantien, Kaplan Richard S., Rubinstein Larry, Verweij Jaap, Van Glabbeke Martine, van Oosterom Allan T., Christian Michaele C., Gwyther Steve G., New Guidelines to Evaluate the Response to Treatment in Solid Tumors, 10.1093/jnci/92.3.205
  2. Eisenhauer E.A., Therasse P., Bogaerts J., Schwartz L.H., Sargent D., Ford R., Dancey J., Arbuck S., Gwyther S., Mooney M., Rubinstein L., Shankar L., Dodd L., Kaplan R., Lacombe D., Verweij J., New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1), 10.1016/j.ejca.2008.10.026
  3. Padhani Anwar R., Liu Guoying, Mu-Koh Dow, Chenevert Thomas L., Thoeny Harriet C., Takahara Taro, Dzik-Jurasz Andrew, Ross Brian D., Van Cauteren Marc, Collins David, Hammoud Dima A., Rustin Gordon J.S., Taouli Bachir, Choyke Peter L., Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and Recommendations, 10.1593/neo.81328
  4. Brindle Kevin M, Detection of apoptosis in tumors using magnetic resonance imaging and spectroscopy, 10.1016/s0065-2571(01)00025-5
  5. Tunariu N, Kaye S B, deSouza N M, Functional imaging: what evidence is there for its utility in clinical trials of targeted therapies?, 10.1038/bjc.2011.579
  6. Jordan Bénédicte F., Runquist Matthew, Raghunand Natarajan, Baker Amanda, Williams Ryan, Kirkpatrick Lynn, Powis Garth, Gillies Robert J., Dynamic Contrast-Enhanced and Diffusion MRI Show Rapid and Dramatic Changes in Tumor Microenvironment in Response to Inhibition of HIF-1α Using PX-478, 10.1593/neo.04628
  7. Chen J.-H., Mehta R.S., Baek H.-M., Nie K., Liu H., Lin M.Q., Yu H.J., Nalcioglu O., Su M.-Y., Clinical characteristics and biomarkers of breast cancer associated with choline concentration measured by 1H MRS, 10.1002/nbm.1595
  8. Glunde, Nat Rev Cancer, 11, 835 (2011)
  9. Radermacher K. A., Magat J., Bouzin C., Laurent S., Dresselaers T., Himmelreich U., Boutry S., Mahieu I., Vander Elst L., Feron O., Muller R. N, Jordan B. F., Gallez B., Multimodal assessment of early tumor response to chemotherapy: comparison between diffusion-weighted MRI, 1H-MR spectroscopy of choline and USPIO particles targeted at cell death : EARLY ASSESSMENT OF TUMOR RESPONSE TO CHEMOTHERAPY, 10.1002/nbm.1765
  10. Barwick Tara, Bencherif Badreddine, Mountz James M., Avril Norbert, Molecular PET and PET/CT imaging of tumour cell proliferation using F-18 fluoro-L-thymidine: a comprehensive evaluation : , 10.1097/mnm.0b013e32832ee93b
  11. Soloviev Dmitry, Lewis David, Honess Davina, Aboagye Eric, [18F]FLT: An imaging biomarker of tumour proliferation for assessment of tumour response to treatment, 10.1016/j.ejca.2011.11.035
  12. Shields Anthony F., Grierson John R., Kozawa Susie M., Zheng Minna, Development of labeled thymidine analogs for imaging tumor proliferation, 10.1016/0969-8051(95)02005-5
  13. Gallagher F. A., Kettunen M. I., Hu D.-E., Jensen P. R., Zandt R. i. t, Karlsson M., Gisselsson A., Nelson S. K., Witney T. H., Bohndiek S. E., Hansson G., Peitersen T., Lerche M. H., Brindle K. M., Production of hyperpolarized [1,4-13C2]malate from [1,4-13C2]fumarate is a marker of cell necrosis and treatment response in tumors, 10.1073/pnas.0911447106
  14. Nguyen Q.-D., Smith G., Glaser M., Perumal M., Arstad E., Aboagye E. O., Positron emission tomography imaging of drug-induced tumor apoptosis with a caspase-3/7 specific [18F]-labeled isatin sulfonamide, 10.1073/pnas.0901310106
  15. Karroum Oussama, Kengen Julie, Danhier Pierre, Magat Julie, Mignion Lionel, Bouzin Caroline, Verrax Julien, Charette Nicolas, Starkel Peter, Calderon Pedro Buc, Sonveaux Pierre, Feron Oliver, Grégoire Vincent, Gallez Bernard, Jordan Bénédicte F., Tumor reoxygenation following administration of Mitogen-Activated Protein Kinase inhibitors: A rationale for combination with radiation therapy, 10.1016/j.radonc.2012.05.005
  16. Pratilas C. A., Solit D. B., Targeting the Mitogen-Activated Protein Kinase Pathway: Physiological Feedback and Drug Response, 10.1158/1078-0432.ccr-09-3064
  17. Eichler A. F., Batchelor T. T., Henson J. W., Diffusion and perfusion imaging in subacute neurotoxicity following high-dose intravenous methotrexate, 10.1215/15228517-2007-015
  18. Schraml Christina, Schwenzer Nina F., Martirosian Petros, Bitzer Michael, Lauer Ulrich, Claussen Claus D., Horger Marius, Diffusion-Weighted MRI of Advanced Hepatocellular Carcinoma During Sorafenib Treatment: Initial Results, 10.2214/ajr.08.2289
  19. Jordan Bénédicte F., Black Kvar, Robey Ian F., Runquist Matthew, Powis Garth, Gillies Robert J., Metabolite changes in HT-29 xenograft tumors following HIF-1α inhibition with PX-478 as studied by MR spectroscopyin vivo andex vivo, 10.1002/nbm.977
  20. Bonekamp Susanne, Shen Jialin, Salibi Nouha, Lai Hong C., Geschwind Jeff, Kamel Ihab R., Early Response of Hepatic Malignancies to Locoregional Therapy-Value of Diffusion-Weighted Magnetic Resonance Imaging and Proton Magnetic Resonance Spectroscopy : , 10.1097/rct.0b013e3182004bfb
  21. Chen Chiao-Yun, Li Chun-Wei, Kuo Yu-Ting, Jaw Twei-Shiun, Wu Ding-Kwo, Jao Jo-Chi, Hsu Jui-Sheng, Liu Gin-Chung, Early Response of Hepatocellular Carcinoma to Transcatheter Arterial Chemoembolization: Choline Levels and MR Diffusion Constants—Initial Experience, 10.1148/radiol.2392042202
  22. Pucar Darko, Koutcher Jason A., Shah Ankoor, Dyke John P., Schwartz Lawrence, Thaler Howard, Kurhanewicz John, Scardino Peter T., Kelly W. Kevin, Hricak Hedvig, Zakian Kristen L., Preliminary Assessment of Magnetic Resonance Spectroscopic Imaging in Predicting Treatment Outcome in Patients with Prostate Cancer at High Risk for Relapse, 10.3816/cgc.2004.n.028
  23. Beloueche-Babari, Cancer Res, 65, 3356 (2005)
  24. Liu D, Hutchinson O C, Osman S, Price P, Workman P, Aboagye E O, Use of radiolabelled choline as a pharmacodynamic marker for the signal transduction inhibitor geldanamycin, 10.1038/sj.bjc.6600558
  25. Jiménez Benilde, del Peso Luis, Montaner Silvia, Esteve Pilar, Lacal Juan Carlos, Generation of phosphorylcholine as an essential event in the activation of Raf-1 and MAP-kinases in growth factors-induced mitogenic stimulation, 10.1002/jcb.240570114
  26. Glunde K., Shah T., Winnard P. T., Raman V., Takagi T., Vesuna F., Artemov D., Bhujwalla Z. M., Hypoxia Regulates Choline Kinase Expression through Hypoxia-Inducible Factor-1  Signaling in a Human Prostate Cancer Model, 10.1158/0008-5472.can-07-2678
  27. Siemerink E., Mulder N. H., Brouwers A. H., Hospers G. A., Early prediction of response to sorafenib treatment in patients with hepatocellular carcinoma (HCC) with 18F- fluorodeoxyglucose-positron emission tomography (18F-FDG-PET), 10.1200/jco.2008.26.15_suppl.15600
  28. Sohn H.-J., Yang Y.-J., Ryu J.-S., Oh S. J., Im K. C., Moon D. H., Lee D. H., Suh C., Lee J.-S., Kim S.-W., [18F]Fluorothymidine Positron Emission Tomography before and 7 Days after Gefitinib Treatment Predicts Response in Patients with Advanced Adenocarcinoma of the Lung, 10.1158/1078-0432.ccr-08-0312
  29. Solit D. B., Santos E., Pratilas C. A., Lobo J., Moroz M., Cai S., Blasberg R., Sebolt-Leopold J., Larson S., Rosen N., 3'-Deoxy-3'-[18F]Fluorothymidine Positron Emission Tomography Is a Sensitive Method for Imaging the Response of BRAF-Dependent Tumors to MEK Inhibition, 10.1158/0008-5472.can-07-2976
  30. Leyton J., Smith G., Lees M., Perumal M., Nguyen Q.-d., Aigbirhio F. I., Golovko O., He Q., Workman P., Aboagye E. O., Noninvasive imaging of cell proliferation following mitogenic extracellular kinase inhibition by PD0325901, 10.1158/1535-7163.mct-08-0264
  31. Peng Chang-Liang, Guo Wei, Ji Tao, Ren Tingting, Yang Yi, Li Da-Sen, Qu Hua yi, Li Xiao, Tang Shun, Yan Tai-Qiang, Tang Xiao-Dong, Sorafenib induces growth inhibition and apoptosis in human synovial sarcoma cells via inhibiting the RAF/MEK/ERK signaling pathway, 10.4161/cbt.8.18.9208
  32. Huether Alexander, Höpfner Michael, Baradari Viola, Schuppan Detlef, Scherübl Hans, Sorafenib alone or as combination therapy for growth control of cholangiocarcinoma, 10.1016/j.bcp.2006.12.031
  33. Plastaras J. P., Kim S.-H., Liu Y. Y., Dicker D. T., Dorsey J. F., McDonough J., Cerniglia G., Rajendran R. R., Gupta A., Rustgi A. K., Diehl J. A., Smith C. D., Flaherty K. T., El-Deiry W. S., Cell Cycle Dependent and Schedule-Dependent Antitumor Effects of Sorafenib Combined with Radiation, 10.1158/0008-5472.can-07-1473
  34. Jain R. K., Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy, 10.1126/science.1104819
  35. Volpe John P., Hunter Nancy, Basic Ivan, Milas Luka, Metastatic properties of murine sarcomas and carcinomas I. Positive correlation with lung colonization and lack of correlation with s.c. tumor take, 10.1007/bf01585082
  36. Yun Mikyung, Oh Seung Jun, Ha Hyun-Joon, Ryu Jin Sook, Moon Dae Hyuk, High radiochemical yield synthesis of 3′-deoxy-3′-[18F]fluorothymidine using (5′-O-dimethoxytrityl-2′-deoxy-3′-O-nosyl-β-D-threo pentofuranosyl)thymine and its 3-N-BOC-protected analogue as a labeling precursor, 10.1016/s0969-8051(02)00409-2
  37. Huisman Marc C., Reder Sybille, Weber Axel W., Ziegler Sibylle I., Schwaiger Markus, Performance evaluation of the Philips MOSAIC small animal PET scanner, 10.1007/s00259-006-0271-7